DEBx Medical
Medical technology company developing innovative solutions for chronic wound treatment, including diabetic foot ulcers, using electrochemical debridement technology.
Notes
DEBx Medical is a medical technology company based in Belgium focused on developing innovative treatments for chronic wounds. The company's technology uses electrochemical debridement to treat difficult-to-heal wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers.
The company's approach aims to provide a more effective and less painful alternative to traditional wound debridement methods. Chronic wounds represent a significant healthcare burden, particularly in aging populations and patients with diabetes.
DEBx Medical is part of the TVM Capital Healthcare portfolio, which focuses on healthcare investments in growth markets.
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Portfolio company of TVM Capital Healthcare
- Focused on chronic wound treatment
- Electrochemical debridement technology
- Addresses diabetic foot ulcers and other chronic wounds
- Based in Belgium
- CE marked device for European market
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| TVM Capital Healthcare | Dubai, UAE & Munich, Germany | biotech-focused | series-aseries-b+1 | 10 |